The 2022 update of the Global Strategy for Asthma Management and Prevention incorporates new scientific information about asthma based on a review of recent scientific literature by an international panel of experts on the GINA Science Committee. This comprehensive and practical resource about one of the most common chronic lung diseases ...

The 2022 GINA Main Report provides a comprehensive guide on global asthma management and prevention strategies.

2023年2月8日 · GINA recommends that all adults, adolescents and most children with asthma should receive inhaled corticosteroid (ICS)-containing therapy to reduce the risk of severe exacerbations, either taken...

2022年5月6日 · 全球哮喘防治创议（GINA）于5月3日在线发布了最新版的哮喘管理和预防策略——“GINA 2022”。 下面让我们来看一下2022年GINA的具体更新要点。 扩展和澄清了GINA年度报告更新的方法学，包括：基于GRADE证据分级的相关审查，以及发布前经过广泛的外部审查 (p.10)。 进一步的证据表明，控制良好的轻中度哮喘患者患重症 COVID-19 的风险并未增加，但对于需要口服糖皮质激素 (OCS) 的哮喘患者以及需要住院的重症哮喘患者而言，罹患重症的风 …

2022年世界哮喘病日（5月4日）发布了2022版全球哮喘管理和预防策略（GINA 2022），其中纳入了有关哮喘的新科学证据。 我国哮喘患病率呈逐年增长趋势，且目前我国哮喘总体控制水平尚不理想。 本文主要对GINA 2022的更新要点进行解读，探讨COVID-19流行期间哮喘的管理问题，并提出对国内哮喘诊治的借鉴意义。 点击此处查看《2022 GINA 报告：全球哮喘管理和预防战略》 …

GINA guidance is adopted by national asthma guidelines in many countries, adapted to fit local healthcare systems, practices, and resource availability. GINA is independent of industry, funded...

2023年2月1日 · GINA guidance is adopted by national asthma guidelines in many countries, adapted to fit local healthcare systems, practices, and resource availability. GINA is independent of industry,...

GINA now recommends that all adults and adolescents with asthma should receive either as needed (in mild asthma) or daily ICS-containing controller treatment to reduce their risk for serious ...

The 2024 update of the Global Strategy for Asthma Management and Prevention incorporates new scientific information about asthma based on a review of recent scientific literature by an international panel of experts on the GINA Science Committee.

2022年1月1日 · The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an annually updated evidence-based strategy for asthma management and prevention, which can be adapted for local circumstances (e.g., medication availability). This article summarizes key recommendations from GINA 2021, …